CLINICAL_TRIALS
trial_result
· 2023-01-09
Clinical Trial Update: Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis [Phase 2]
Summary
Phase 2 study of pirfenidone in fibrotic hypersensitivity pneumonitis was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evans Fernandez Perez | Conditions: Interstitial Lung Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-01-09